Back

Long-term outcome in the pivotal MOMENTUM 3 trial: medical resource use and cost implications

28 May 2018 (08:45 - 08:55)
Organised by:
Congress Presentation Part of: Late breaking trial III - Innovative and device therapy Ventricular Assist Devices HFA Premium Access Heart Failure 2018

About the speaker

Photo
Professor Mandeep Mehra

Mass General Brigham, Boston (United States of America)

11 More presentations in this session

Presentation thumbnail
Upgrades from a previous device compared to de novo CRT implantation in the CRT Survey II: a European Society of Cardiology survey of cardiac resynchronization therapy in 11.088 patients
Professor C. Linde (Stockholm, SE)
Slides Video
Presentation thumbnail
Discussion - CRT Survey II
Video
Presentation thumbnail
Discussion - MOMENTUM 3
Video
Presentation thumbnail
Cardiac contractility modulation improves peak VO2, long-term survival and hospitalisations in heart failure with reduced ejection fraction; evidence from FIX-5C and the EU registry
Professor G. Hasenfuss (Goettingen, DE)
Slides Video
Presentation thumbnail
Discussion - FIX-5C and the EU registry
Video

Access the full session

Session thumbnail
Late breaking trial III - Innovative and device therapy

The Event

Event poster

Heart Failure 2018

28 May 2018 08:45 CET
You may be interested in
thumbnail
Congress Session
Treatment of HFrEF
1 September 2025
thumbnail
Congress Presentation
Assessing the impact of hemodynamic monitoring with CardioMEMS on heart failure patients: a cost-effectiveness analysis
21 May 2023
thumbnail
Webinar
The year in cardiology 2018
12 December 2018
thumbnail
Congress Session
HFA clinical trial course in a nutshell
17 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources